Board of Directors

Perrigo is a leading global consumer-focused self-care company. Our vision is to make lives better by bringing “Quality, Affordable Self-Care Products” that consumers trust everywhere they are sold. The Company is a leading provider of health and wellness solutions that enhance individual well-being by empowering consumers to proactively prevent or treat conditions that can be self-managed.

Learn More

Geoffrey M. Parker

  • Independent Director
  • Director since 2016

Committees

  • Audit

Experience

  • 2023 - Present Executive Vice Present & Chief Financial Officer, Allogene Therapeutics, Inc, a biotechnology company.
  • 2017 - 2023 Chief Operating Officer & Chief Financial Officer, Tricida, Inc, a biotechnology company.
  • 2010 - 2015 Chief Financial Officer, Anacor Pharmaceuticals, Inc., a biotechnology company.
  • 1997 - 2009 Managing Director and Partner, Healthcare Investment Banking, Goldman Sachs, a multinational investment bank and financial service company.

Other Public Company Directorships

  • 2021 - March 2024 Better Therapeutics (NASDAQ: BTTX)
  • 2009 - 2022 ChemoCentryx (NASDAQ: CCXI)
  • 2016 - 2019 Genomic Health (NASDAQ: GHDX)
  • 2016 - 2017 Sunesis Pharmaceuticals (NASDAQ: SNSS)

Notable Experience and Key Skill Sets

  • Mr. Parker has developed expertise across the healthcare sector through his extensive experience as a senior executive at multiple biotechnology companies, as a board member at multiple healthcare companies and as an investment banker to the healthcare industry.
  • He brings a unique understanding of trends in the healthcare industry including experience with emerging technologies and regulatory strategies.
  • Mr. Parker also provides valuable perspective on areas of financial management and capital allocation. He has extensive capital markets and M&A experience as an experienced chief financial officer across three companies and over twenty years as an investment banker.